Daesung Microbiological Labs. Co. Ltd
KOSDAQ-listed animal pharmaceutical company producing over 150 veterinary products including vaccines and antibiotics.
As of 2026-10-10, Daesung Microbiological Labs. Co. Ltd has 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1966 and listed on KOSDAQ in 2000, Daesung Microbiological Labs is a veterinary pharmaceutical company. It manufactures and sells over 150 types of animal medicines including vaccines, antibiotics, antimicrobials, dewormers, nutritional supplements, and probiotic enzyme products, and has licensed avian metapneumovirus vaccine (working title: Chicken Pneumo Live Vaccine) manufacturing technology from Carb Inc. while jointly researching an avian adenovirus vaccine (working title: Chicken Adeno2 Chickenvac) with Konkuk University for commercialization. Revenue for the period was approximately KRW 26.0 billion, with domestic sales of KRW 18.7 billion (72%) and exports of KRW 7.3 billion (28%) across eight countries including Pakistan, Vietnam, and Russia.
Products & technology
- Veterinary pharmaceuticals (150+ types including vaccines, antibiotics, antimicrobials, dewormers)Disease prevention and treatment for livestock
R&D and key agreements
Source: DART corporate disclosure닭 뉴모 생백신(가칭) · 조류(닭) 메타뉴모 바이러스 감염증 · 기술이전 완료, 역가증진시험 및 동결건조백신 안정성시험 진행중 · Manufacturing technology licensed from Carb Inc.; royalty paid based on sales volume
닭 아데노2 치큰백(가칭) · 조류(닭) 아데노 바이러스 감염증 · 배양방법 및 역가증진시험 진행중 · Joint research with Konkuk University on commercializing an inactivated avian adenovirus combination vaccine
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matchedPatents
KIPRIS · applicant-matchedRejected · 2020-06 · Application 1020200071330
Rejected · 2019-01 · Application 1020190005571
Expired · 2018-08 · Application 1020180089678
PCT · Published · 2016-06 · Application PCT/KR2016/006282
Registered · 2016-03 · Application 1020160025583
Rejected · 2015-06 · Application 1020150086360
Registered · 2014-06 · Application 1020140070941
Registered · 2012-10 · Application 1020120109818
Registered · 2008-11 · Application 1020080116967
Registered · 2008-07 · Application 1020080067209
Show 28 more patents
Rejected · 2007-01 · Application 1020070009081
Expired · 2003-12 · Application 1020030096480
Rejected · 2001-03 · Application 1020010016262
Expired · 2000-10 · Application 1020000058222
EP · Published · 2000-01 · Application 00900932.5
PCT · Published · 2000-01 · Application PCT/KR2000/000002
Expired · 1999-12 · Application 1019990056276
Expired · 1999-12 · Application 1019990056277
Expired · 1999-12 · Application 1019990056274
Expired · 1999-12 · Application 1019990056275
Expired · 1999-07 · Application 1019990027826
Expired · 1999-04 · Application 1019990013597
Expired · 1998-12 · Application 1019980056952
EP · Registered · 1998-03 · Application 98908305.0
PCT · Published · 1998-03 · Application PCT/KR1998/000056
Expired · 1997-03 · Application 1019970010947
Expired · 1997-03 · Application 1019970010948
Expired · 1997-03 · Application 1019970007088
Expired · 1996-03 · Application 1019960006817
Expired · 1995-10 · Application 1019950036731
Expired · 1994-05 · Application 1019940010312
Expired · 1991-12 · Application 1019910022989
Expired · 1991-01 · Application 1019910001232
Expired · 1990-11 · Application 1019900018951
Expired · 1990-07 · Application 1019900011743
Expired · 1989-10 · Application 1019890015450
Expired · 1982-10 · Application 1019820004489
Expired · 1982-10 · Application 1019820004490
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot7
- GoogleGoogleOther2
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Daesung Microbiological Labs. Co. Ltd and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition